| Literature DB >> 15743547 |
Abstract
Childhood ependymomas, which comprise approximately 10% to 15% of all brain tumors arising in patients less than 18 years of age, remain a highly problematic group of tumors to treat. Relapse-free survival rates vary significantly in contemporary series, and therapeutic approaches remain unsettled.Entities:
Mesh:
Year: 2005 PMID: 15743547 DOI: 10.1007/s11910-005-0007-2
Source DB: PubMed Journal: Curr Neurol Neurosci Rep ISSN: 1528-4042 Impact factor: 5.081